Industry · 7 companies

Biotechnology: In Vitro & In Vivo Diagnostic Substances industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances industry, analyzed as one company and through its members.

Market cap

$66.1B

Net margin

-4.0%

Revenue growth

3.5%

1-year return

6.4%

Sector

• Health Care sector

Largest companies

• IDXX · IDEXX Laboratories Inc.
• LNTH · Lantheus Holdings Inc.
• ORKA · Oruka Therapeutics Inc.
• NEOG · Neogen Corporation
• CLDX · Celldex Therapeutics Inc.
• NTLA · Intellia Therapeutics Inc.
• QDEL · QuidelOrtho Corporation

For information only, not investment advice. Data may contain errors. Disclaimer · Sources